scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1028907553 |
P356 | DOI | 10.1007/S13277-015-4581-X |
P698 | PubMed publication ID | 26678889 |
P50 | author | Guoguang Zheng | Q49885423 |
P2093 | author name string | Lei Zhu | |
Yong Yu | |||
Chen Tian | |||
M James You | |||
Yizhuo Zhang | |||
P2860 | cites work | Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer | Q24307748 |
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy | Q24337757 | ||
MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma | Q27350129 | ||
MicroRNA-9 Modulates Hes1 ultradian oscillations by forming a double-negative feedback loop | Q33920068 | ||
Hes1 is a target of microRNA-23 during retinoic-acid-induced neuronal differentiation of NT2 cells | Q34206217 | ||
Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs. | Q34230583 | ||
Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia | Q34232877 | ||
Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells | Q34421127 | ||
Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells | Q35040064 | ||
Regulation of cancer metastasis by microRNAs | Q35052860 | ||
HES1 is an independent prognostic factor for acute myeloid leukemia | Q35541938 | ||
Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment | Q36618643 | ||
Preferential eradication of acute myelogenous leukemia stem cells by fenretinide | Q36747742 | ||
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. | Q37010564 | ||
In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling | Q37101484 | ||
Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells | Q37297755 | ||
Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept. | Q37808236 | ||
Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance | Q38010349 | ||
Identifying leukemia stem cells--is it feasible and does it matter? | Q38028260 | ||
Acute myeloid leukemia in adolescents and young adults: challenging aspects | Q38250288 | ||
MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias | Q38252974 | ||
Notch activation inhibits AML growth and survival: a potential therapeutic approach | Q39202885 | ||
Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity | Q39422497 | ||
Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. | Q39782714 | ||
Hes1 suppresses acute myeloid leukemia development through FLT3 repression | Q42186875 | ||
Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication | Q43806378 | ||
Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia | Q45216078 | ||
Leukemia stem cells | Q46509360 | ||
miR-9 is a tumor suppressor in pediatric AML with t(8;21). | Q48336259 | ||
A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients. | Q50609353 | ||
Mouse microRNA-23b regulates expression of Hes1 gene in P19 cells. | Q51097380 | ||
A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes. | Q54180550 | ||
HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia | Q85410943 | ||
P433 | issue | 6 | |
P921 | main subject | karyotype | Q189967 |
acute myeloid leukemia | Q264118 | ||
microRNA | Q310899 | ||
leukemia | Q29496 | ||
P304 | page(s) | 7461-7471 | |
P577 | publication date | 2015-12-17 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. | |
P478 | volume | 37 |
Q52640764 | Anti-miRNA oligonucleotides: A comprehensive guide for design. |
Q88446413 | Clinical characteristics and prognosis of multiple myeloma with bone-related extramedullary disease at diagnosis |
Q92617526 | Clinical relevance of PET/CT in patients with newly diagnosed multiple myeloma |
Q90538487 | Inhibition of SIRT1 by microRNA-9, the key point in process of LPS-induced severe inflammation |
Q58800121 | MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2 |
Q36511384 | MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients |
Q38735859 | MicroRNA: an important regulator in acute myeloid leukemia |
Q48104779 | MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia. |
Q33844728 | Prognostic Value of microRNA-9 in Various Cancers: a Meta-analysis |
Q64284722 | Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia |
Q39109921 | Targeting acute myeloid leukemia stem cell signaling by natural products. |
Q55174811 | The versatile nature of miR-9/9* in human cancer. |
Q37709531 | miRNAs in acute myeloid leukemia |